AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $26,291,000 | +50.7% | 491,615 | 0.0% | 0.07% | -9.5% |
| Q1 2020 | $17,443,000 | -25.7% | 491,615 | 0.0% | 0.07% | -14.9% |
| Q4 2019 | $23,474,000 | -7.9% | 491,615 | -37.5% | 0.09% | -3.3% |
| Q3 2019 | $25,487,000 | -25.6% | 786,615 | +14.6% | 0.09% | -33.8% |
| Q2 2019 | $34,249,000 | -26.0% | 686,615 | 0.0% | 0.14% | -41.1% |
| Q1 2019 | $46,305,000 | +123.6% | 686,615 | +52.9% | 0.23% | +71.1% |
| Q4 2018 | $20,708,000 | -61.3% | 449,115 | -35.3% | 0.14% | -46.6% |
| Q3 2018 | $53,517,000 | -8.4% | 693,954 | +0.0% | 0.25% | -7.0% |
| Q2 2018 | $58,438,000 | +6.8% | 693,789 | +3.7% | 0.27% | -4.9% |
| Q1 2018 | $54,694,000 | +87.0% | 668,789 | +30.7% | 0.29% | +66.3% |
| Q4 2017 | $29,250,000 | -4.1% | 511,619 | +12.0% | 0.17% | -21.5% |
| Q3 2017 | $30,489,000 | – | 456,761 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |